FP7
MASTERSWITCH
Mechanisms to Attack Steering Effectors of Rheumatoid Syndromes with Innovated Therapy Choices
- Programme
- Seventh Framework Programme
- Started
- Ends
- Duration
- 60 months
- Total cost
- EUR 14,805,808
- EU contribution
- EUR 11,235,980
- Participants
- 20 from 9 countries
- Topic
- FP7_HEALTH-2007-2.4.5-12
- Grant agreement
- 223404
Coordinated by Academisch Ziekenhuis Leiden (NLNetherlands).
Consortium
EU contribution per participant as the open data of CORDIS states it; for a participant with linked third parties it may include their share, and a participant whose amount the data does not hold or cannot make consistent shows Not stated. A participant who left the project is not listed; see the history below.
| Organisation | Country | Role | EU contribution | Recognised by |
|---|---|---|---|---|
| Academisch Ziekenhuis Leiden | NLNetherlands | Coordinator | EUR 2,312,612 | PIC (1.00) |
| Medizinische Universitaet Wien | ATAustria | Participant | EUR 806,200 | PIC (1.00) |
| University of Zurich | CHSwitzerland | Participant | EUR 675,000 | PIC (1.00) |
| Friedrich-Alexander-Universitaet Erlangen-Nuernberg | DEGermany | Participant | EUR 501,444 | PIC (1.00) |
| Universitat Zu Koln | DEGermany | Participant | EUR 500,000 | known name (0.97) |
| Agencia Estatal Consejo Superior de Investigaciones Cientificas | ESSpain | Participant | EUR 415,512 | PIC (1.00) |
| Centre National de la Recherche Scientifique Cnrs | FRFrance | Participant | EUR 695,000 | known name (0.95) |
| Hybrigenics SA | FRFrance | Participant | EUR 411,527 | PIC (1.00) |
| Cranfield University | GBUnited Kingdom | Participant | EUR 210,001 | known name (0.95) |
| Imperial College of Science Technology and Medicine | GBUnited Kingdom | Participant | EUR 170,010 | PIC (1.00) |
| King's College London | GBUnited Kingdom | Participant | EUR 121,875 | known name (0.95) |
| MaimoniDex (UK) Ltd | GBUnited Kingdom | Participant | EUR 412,500 | PIC (1.00) |
| The Chancellor, Masters and Scholars of the University of Oxford | GBUnited Kingdom | Participant | EUR 225,000 | PIC (1.00) |
| The University of Sussex | GBUnited Kingdom | Participant | EUR 61,874 | known name (0.95) |
| University of Glasgow | GBUnited Kingdom | Participant | EUR 423,828 | known name (0.95) |
| University of Leeds | GBUnited Kingdom | Participant | EUR 607,705 | known name (0.95) |
| Biomedcode Ellas Anonimi Eteria Epistimonikis Kai Texnologikis Erevnas Kai Emborikis Ekmetallefsis Epharmogon Iatrikis | GRGreece | Participant | EUR 412,500 | PIC (1.00) |
| Erevnitiko Kentro Vioiatrikon Epistimon Alexandros Flemingk | GRGreece | Participant | EUR 944,480 | PIC (1.00) |
| Karolinska Institutet | SESweden | Participant | EUR 1,178,912 | known name (0.95) |
| Redoxis AB | SESweden | Participant | EUR 150,000 | PIC (1.00) |
Changes of the consortium
First seen on with 20 participants from 9 countries.
A snapshot of each project's members is taken once a month; a change is recorded when a snapshot differs from the one before. A project with no change listed has had the same members since it was first observed.
Project page on CORDIS (opens in new tab)
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them.
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.